The University of Southampton
University of Southampton Institutional Repository

Global perspectives on the burden and management of hypophosphataemic osteomalacia in adult patients: an International Osteoporosis Foundation (IOF) survey

Global perspectives on the burden and management of hypophosphataemic osteomalacia in adult patients: an International Osteoporosis Foundation (IOF) survey
Global perspectives on the burden and management of hypophosphataemic osteomalacia in adult patients: an International Osteoporosis Foundation (IOF) survey
Summary: this survey collected global perspectives on the burden and management of hypophosphataemic osteomalacia in adults through the International Osteoporosis Foundation (IOF). The IOF network represents a valuable international resource for understanding the burden and management of rare bone disorders.

Purpose: to investigate the international burden and management of hypophosphataemic osteomalacia (HO) in adult patients.

Methods: a survey was developed consisting of seven questions about respondents and their experiences of managing HO, with a second section inviting additional non-identifying information on up to five patients. The survey was disseminated to the International Osteoporosis Foundation (IOF) network.

Results: forty clinicians from 24 countries responded, with most based in academic centres. Respondents reported managing over 1000 adult patients with HO, primarily diagnosed with X-linked hypophosphataemia (XLH; 35%), tumour-induced osteomalacia (TIO; 24%), and fibrous dysplasia/McCune–Albright syndrome (FD/MAS; 16%). Management varied by diagnosis, reflecting differences in the underlying pathophysiology and clinical manifestations of the disorders. Respondents provided additional information on 19 patients with XLH, 28 with TIO, and 9 with other HO disorders. Common symptoms across XLH and TIO included bone pain (XLH, 67%; TIO, 88%), muscle pain (XLH, 61%; TIO, 76%), and muscle weakness (XLH, 61%; TIO, 88%). Many patients with XLH had discontinued phosphate and vitamin D therapies, with a subset initiating burosumab treatment. In contrast, phosphate and vitamin D were commonly used in TIO, with many patients being considered for tumour resection and limited burosumab use. Pain medication use, including opiates, was relatively high across all patients.

Conclusion: adults with HO experience a significant burden of musculoskeletal symptoms. Future efforts should focus on global education of healthcare professionals. The IOF network represents a valuable international resource for understanding the burden and management of rare bone disorders.
Hypophosphataemic osteomalacia, IOF, Rare bone disorder, Real-world survey, Tumour-induced osteomalacia, X-linked hypophosphataemia
1862-3522
Brandi, Maria Luisa
b42820a8-1622-4a0d-8f9b-3f53f2e90180
Halbout, Philippe
a6bac6c8-e463-4c0d-bb75-389ad2b0b945
Pierroz, Dominique D.
b19cd2e8-fdbe-4992-bc11-b536abeee614
Harvey, Nicholas C.
ce487fb4-d360-4aac-9d17-9466d6cba145
Brandi, Maria Luisa
b42820a8-1622-4a0d-8f9b-3f53f2e90180
Halbout, Philippe
a6bac6c8-e463-4c0d-bb75-389ad2b0b945
Pierroz, Dominique D.
b19cd2e8-fdbe-4992-bc11-b536abeee614
Harvey, Nicholas C.
ce487fb4-d360-4aac-9d17-9466d6cba145

Brandi, Maria Luisa, Halbout, Philippe, Pierroz, Dominique D. and Harvey, Nicholas C. (2026) Global perspectives on the burden and management of hypophosphataemic osteomalacia in adult patients: an International Osteoporosis Foundation (IOF) survey. Archives of Osteoporosis, 21 (1), [61]. (doi:10.1007/s11657-026-01692-y).

Record type: Article

Abstract

Summary: this survey collected global perspectives on the burden and management of hypophosphataemic osteomalacia in adults through the International Osteoporosis Foundation (IOF). The IOF network represents a valuable international resource for understanding the burden and management of rare bone disorders.

Purpose: to investigate the international burden and management of hypophosphataemic osteomalacia (HO) in adult patients.

Methods: a survey was developed consisting of seven questions about respondents and their experiences of managing HO, with a second section inviting additional non-identifying information on up to five patients. The survey was disseminated to the International Osteoporosis Foundation (IOF) network.

Results: forty clinicians from 24 countries responded, with most based in academic centres. Respondents reported managing over 1000 adult patients with HO, primarily diagnosed with X-linked hypophosphataemia (XLH; 35%), tumour-induced osteomalacia (TIO; 24%), and fibrous dysplasia/McCune–Albright syndrome (FD/MAS; 16%). Management varied by diagnosis, reflecting differences in the underlying pathophysiology and clinical manifestations of the disorders. Respondents provided additional information on 19 patients with XLH, 28 with TIO, and 9 with other HO disorders. Common symptoms across XLH and TIO included bone pain (XLH, 67%; TIO, 88%), muscle pain (XLH, 61%; TIO, 76%), and muscle weakness (XLH, 61%; TIO, 88%). Many patients with XLH had discontinued phosphate and vitamin D therapies, with a subset initiating burosumab treatment. In contrast, phosphate and vitamin D were commonly used in TIO, with many patients being considered for tumour resection and limited burosumab use. Pain medication use, including opiates, was relatively high across all patients.

Conclusion: adults with HO experience a significant burden of musculoskeletal symptoms. Future efforts should focus on global education of healthcare professionals. The IOF network represents a valuable international resource for understanding the burden and management of rare bone disorders.

Text
IOF survey manuscript second submission 2.00 STJ 23Feb26 - Accepted Manuscript
Available under License Creative Commons Attribution.
Download (1MB)
Text
s11657-026-01692-y - Version of Record
Available under License Creative Commons Attribution.
Download (1MB)

More information

Accepted/In Press date: 13 March 2026
e-pub ahead of print date: 30 March 2026
Published date: 30 March 2026
Keywords: Hypophosphataemic osteomalacia, IOF, Rare bone disorder, Real-world survey, Tumour-induced osteomalacia, X-linked hypophosphataemia

Identifiers

Local EPrints ID: 510955
URI: http://eprints.soton.ac.uk/id/eprint/510955
ISSN: 1862-3522
PURE UUID: 0e15699c-e85b-42df-8441-55f54bf63f69
ORCID for Nicholas C. Harvey: ORCID iD orcid.org/0000-0002-8194-2512

Catalogue record

Date deposited: 28 Apr 2026 16:30
Last modified: 29 Apr 2026 01:40

Export record

Altmetrics

Contributors

Author: Maria Luisa Brandi
Author: Philippe Halbout
Author: Dominique D. Pierroz

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×